Follow on Telegram

science/health

Semaglutide Linked to Reduced Psychiatric Hospitalization Risk in Bipolar Disorder Study

A large Swedish study published in JAMA Psychiatry has found that semaglutide—the active ingredient in Ozempic and Wegovy—may offer unexpected mental health benefits for people with bipolar disorder. Researchers analyzed data from nearly 15,000 individuals with bipolar disorder and found that those using semaglutide had a 21%

Scientists Identify New Vulnerability in Treatment-Resistant Prostate Cancer

Prostate cancer is one of the most common cancers affecting men worldwide, and while many cases respond well to initial treatments, a significant number develop resistance over time. When this happens, the cancer can become especially difficult to treat. A key mechanism behind this resistance involves what researchers call lineage

Study Links Common Dry-Cleaning Chemical to Significantly Elevated Liver Fibrosis Risk

A chemical widely used in dry cleaning and found in certain consumer products may pose a previously underappreciated risk to liver health. A study published in Science Daily reports that individuals with detectable levels of tetrachloroethylene (PCE) in their bloodstream were three times more likely to develop significant liver fibrosis—

The Frontier of AI Consciousness: Scientists Grapple with Detecting Mind in Machines

As AI systems become increasingly sophisticated, a challenging question has moved from philosophy seminars into scientific laboratories: how would we know if an AI system were conscious? The search for consciousness inside AI represents one of the most profound challenges in contemporary research. Unlike measuring intelligence or capability, consciousness lacks

What One of the First Randomized Trials of AI in Medicine Tells Us About Moving from Algorithms to Patient Outcomes

The integration of artificial intelligence into clinical medicine has accelerated rapidly, but evidence about whether AI tools actually improve patient outcomes in practice has remained limited. A study published in Nature's Nature Medicine represents one of the first randomized trials designed specifically to test an AI system in

AI-Generated Drug Shows Early Promise for Slowing Aging Process

Early-stage research indicates that a drug designed using artificial intelligence could potentially slow certain aspects of the aging process, according to findings published by The New York Times. The drug represents a collaborative effort between AI systems and pharmaceutical researchers, where machine learning algorithms were used to identify and synthesize

Study Reveals How Breast Cancer Cells Evade Treatment by Hiding Behind Protective Shields

Researchers have produced detailed maps of breast tumors that reveal a troubling mechanism behind cancer recurrence. The study found that some cancer cells enter a dormant state—essentially hibernating—which allows them to evade chemotherapy and other treatments designed to target rapidly dividing cells. These dormant cells were not distributed